IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Current Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Current Liabilities
kr36.7m
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Current Liabilities
kr429.8m
CAGR 3-Years
52%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Current Liabilities
kr428.8m
CAGR 3-Years
27%
CAGR 5-Years
29%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Current Liabilities
kr357.1m
CAGR 3-Years
61%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Current Liabilities
kr20.5m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Current Liabilities
kr31.6m
CAGR 3-Years
31%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Current Liabilities?
Total Current Liabilities
36.7m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Current Liabilities amounts to 36.7m SEK.

What is IRLAB Therapeutics AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
24%

Over the last year, the Total Current Liabilities growth was 14%. The average annual Total Current Liabilities growth rates for IRLAB Therapeutics AB have been 21% over the past three years , 24% over the past five years .

Back to Top